NEUROCRINE

Neurocrine Biosciences is dedicated to providing breakthrough treatments for patients in need with rare and under-addressed diseases... Neurocrine was founded in 1992 by Wylie Vale, Ph.D., of the Salk Institute for Biological Studies, where he contributed to Nobel Prize-winning work in endocrinology, and award-winning Stanford University neurologist Lawrence Steinman, Ph.D. Since then, we have been developing treatments for rare and under-addressed diseases, sometimes in collaboration with other pharmaceutical companies... Neurocrine has a heritage based in science and collaboration that remains the hallmark of our culture today.

Also known as: Neurocrine Biosciences, Neurocrine Biosciences, Inc.

Primary location: San Diego United States